344 related articles for article (PubMed ID: 34019142)
1. Innate immunity in hepatitis B and D virus infection: consequences for viral persistence, inflammation, and T cell recognition.
Dandri M; Bertoletti A; Lütgehetmann M
Semin Immunopathol; 2021 Aug; 43(4):535-548. PubMed ID: 34019142
[TBL] [Abstract][Full Text] [Related]
2. HDV RNA replication is associated with HBV repression and interferon-stimulated genes induction in super-infected hepatocytes.
Alfaiate D; Lucifora J; Abeywickrama-Samarakoon N; Michelet M; Testoni B; Cortay JC; Sureau C; Zoulim F; Dény P; Durantel D
Antiviral Res; 2016 Dec; 136():19-31. PubMed ID: 27771387
[TBL] [Abstract][Full Text] [Related]
3. Innate immune recognition and modulation in hepatitis D virus infection.
Jung S; Altstetter SM; Protzer U
World J Gastroenterol; 2020 Jun; 26(21):2781-2791. PubMed ID: 32550754
[TBL] [Abstract][Full Text] [Related]
4. A new HDV mouse model identifies mitochondrial antiviral signaling protein (MAVS) as a key player in IFN-β induction.
Suárez-Amarán L; Usai C; Di Scala M; Godoy C; Ni Y; Hommel M; Palomo L; Segura V; Olagüe C; Vales A; Ruiz-Ripa A; Buti M; Salido E; Prieto J; Urban S; Rodríguez-Frias F; Aldabe R; González-Aseguinolaza G
J Hepatol; 2017 Oct; 67(4):669-679. PubMed ID: 28527664
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis-D Virus Infection Is Not Impaired by Innate Immunity but Increases Cytotoxic T-Cell Activity.
Altstetter SM; Quitt O; Pinci F; Hornung V; Lucko AM; Wisskirchen K; Jung S; Protzer U
Cells; 2021 Nov; 10(11):. PubMed ID: 34831475
[TBL] [Abstract][Full Text] [Related]
6. Preclinical assessment of antiviral combination therapy in a genetically humanized mouse model for hepatitis delta virus infection.
Winer BY; Shirvani-Dastgerdi E; Bram Y; Sellau J; Low BE; Johnson H; Huang T; Hrebikova G; Heller B; Sharon Y; Giersch K; Gerges S; Seneca K; Pais MA; Frankel AS; Chiriboga L; Cullen J; Nahass RG; Lutgehetmann M; Toettcher JE; Wiles MV; Schwartz RE; Ploss A
Sci Transl Med; 2018 Jun; 10(447):. PubMed ID: 29950446
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis Delta co-infection in humanized mice leads to pronounced induction of innate immune responses in comparison to HBV mono-infection.
Giersch K; Allweiss L; Volz T; Helbig M; Bierwolf J; Lohse AW; Pollok JM; Petersen J; Dandri M; Lütgehetmann M
J Hepatol; 2015 Aug; 63(2):346-53. PubMed ID: 25795587
[TBL] [Abstract][Full Text] [Related]
8. Humanized chimeric uPA mouse model for the study of hepatitis B and D virus interactions and preclinical drug evaluation.
Lütgehetmann M; Mancke LV; Volz T; Helbig M; Allweiss L; Bornscheuer T; Pollok JM; Lohse AW; Petersen J; Urban S; Dandri M
Hepatology; 2012 Mar; 55(3):685-94. PubMed ID: 22031488
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis D Virus Infection of Mice Expressing Human Sodium Taurocholate Co-transporting Polypeptide.
He W; Ren B; Mao F; Jing Z; Li Y; Liu Y; Peng B; Yan H; Qi Y; Sun Y; Guo JT; Sui J; Wang F; Li W
PLoS Pathog; 2015 Apr; 11(4):e1004840. PubMed ID: 25902143
[TBL] [Abstract][Full Text] [Related]
10. Persistent hepatitis D virus mono-infection in humanized mice is efficiently converted by hepatitis B virus to a productive co-infection.
Giersch K; Helbig M; Volz T; Allweiss L; Mancke LV; Lohse AW; Polywka S; Pollok JM; Petersen J; Taylor J; Dandri M; Lütgehetmann M
J Hepatol; 2014 Mar; 60(3):538-44. PubMed ID: 24280293
[TBL] [Abstract][Full Text] [Related]
11. Mouse models of hepatitis B and delta virus infection.
Dandri M; Lütgehetmann M
J Immunol Methods; 2014 Aug; 410():39-49. PubMed ID: 24631647
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis Delta Virus Acts as an Immunogenic Adjuvant in Hepatitis B Virus-Infected Hepatocytes.
Tham CYL; Kah J; Tan AT; Volz T; Chia A; Giersch K; Ladiges Y; Loglio A; Borghi M; Sureau C; Lampertico P; Lütgehetmann M; Dandri M; Bertoletti A
Cell Rep Med; 2020 Jul; 1(4):100060. PubMed ID: 33205065
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis Delta Virus Alters the Autophagy Process To Promote Its Genome Replication.
Khabir M; Aliche AZ; Sureau C; Blanchet M; Labonté P
J Virol; 2020 Jan; 94(4):. PubMed ID: 31748400
[TBL] [Abstract][Full Text] [Related]
14. New insights into HDV persistence: The role of interferon response and implications for upcoming novel therapies.
Zhang Z; Urban S
J Hepatol; 2021 Mar; 74(3):686-699. PubMed ID: 33276031
[TBL] [Abstract][Full Text] [Related]
15. Interplay between Hepatitis D Virus and the Interferon Response.
Zhang Z; Urban S
Viruses; 2020 Nov; 12(11):. PubMed ID: 33233762
[TBL] [Abstract][Full Text] [Related]
16. Adaptive Immune Responses, Immune Escape and Immune-Mediated Pathogenesis during HDV Infection.
Oberhardt V; Hofmann M; Thimme R; Neumann-Haefelin C
Viruses; 2022 Jan; 14(2):. PubMed ID: 35215790
[TBL] [Abstract][Full Text] [Related]
17. Distinct Cytokine Profiles Correlate with Disease Severity and Outcome in Longitudinal Studies of Acute Hepatitis B Virus and Hepatitis D Virus Infection in Chimpanzees.
Engle RE; De Battista D; Danoff EJ; Nguyen H; Chen Z; Lusso P; Purcell RH; Farci P
mBio; 2020 Nov; 11(6):. PubMed ID: 33203756
[TBL] [Abstract][Full Text] [Related]
18. Does treatment of hepatitis B virus (HBV) infection reduce hepatitis delta virus (HDV) replication in HIV-HBV-HDV-coinfected patients?
Sheldon J; Ramos B; Toro C; Ríos P; Martínez-Alarcón J; Bottecchia M; Romero M; Garcia-Samaniego J; Soriano V
Antivir Ther; 2008; 13(1):97-102. PubMed ID: 18389903
[TBL] [Abstract][Full Text] [Related]
19. Aiming for cure in HBV and HDV infection.
Petersen J; Thompson AJ; Levrero M
J Hepatol; 2016 Oct; 65(4):835-848. PubMed ID: 27270043
[TBL] [Abstract][Full Text] [Related]
20. Analysis of Host Responses to Hepatitis B and Delta Viral Infections in a Micro-scalable Hepatic Co-culture System.
Winer BY; Gaska JM; Lipkowitz G; Bram Y; Parekh A; Parsons L; Leach R; Jindal R; Cho CH; Shrirao A; Novik E; Schwartz RE; Ploss A
Hepatology; 2020 Jan; 71(1):14-30. PubMed ID: 31206195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
